TA loci of Staphylococcus aureus strain FDA209P

Number of TA loci: experimental0; insolico20

TA ID Related MGEs Organism (replicon) Genome accession Toxin Antitoxin Family/Domain
in_silico TA279182 IS/Tn Staphylococcus aureus strain FDA209P (chromosome) NZ_CP123853 NUG19_RS00775 (tsbT) - tsbAT/-
in_silico TA279183 Prophage Prophage Staphylococcus aureus strain FDA209P (chromosome) NZ_CP123853 NUG19_RS05840 (TscT) - TscAT/-
in_silico TA279184 Prophage Prophage Staphylococcus aureus strain FDA209P (chromosome) NZ_CP123853 NUG19_RS05975 (TsaT) - TsaAT/-
in_silico TA279185 - Staphylococcus aureus strain FDA209P (chromosome) NZ_CP123853 NUG19_RS11275 (yoeB) - yefM-yoeB (relBE)/Txe(toxin)
in_silico TA279187 IS/Tn Staphylococcus aureus strain FDA209P (chromosome) NZ_CP123853 NUG19_RS11555 (yoeB) - yefM-yoeB (relBE)/Txe(toxin)
in_silico TA279188 - Staphylococcus aureus strain FDA209P (chromosome) NZ_CP123853 NUG19_RS13185 (TsdT) - TsdAT/-
in_silico TA279189 - Staphylococcus aureus strain FDA209P (chromosome) NZ_CP123853 NUG19_RS13275 (mazF) - mazEF/MazF(toxin)
in_silico TA031016 Prophage Staphylococcus aureus strain FDA209P (chromosome) NZ_AP014942 SAFDA_RS04000 (TsaT) - TsaAT/-
in_silico TA031017 Prophage Staphylococcus aureus strain FDA209P (chromosome) NZ_AP014942 SAFDA_RS04145 (TscT) - TscAT/-
in_silico TA031018 IS/Tn Staphylococcus aureus strain FDA209P (chromosome) NZ_AP014942 SAFDA_RS09320 (tsbT) - tsbAT/-
in_silico TA031022 - Staphylococcus aureus strain FDA209P (chromosome) NZ_AP014942 SAFDA_RS10605 (mazF) - mazEF/MazF(toxin)
in_silico TA031023 - Staphylococcus aureus strain FDA209P (chromosome) NZ_AP014942 SAFDA_RS10695 (TsdT) - TsdAT/-
in_silico TA031024 IS/Tn Staphylococcus aureus strain FDA209P (chromosome) NZ_AP014942 SAFDA_RS12380 (yoeB) - yefM-yoeB (relBE)/Txe(toxin)
in_silico TA031027 - Staphylococcus aureus strain FDA209P (chromosome) NZ_AP014942 SAFDA_RS12680 (yoeB) - yefM-yoeB (relBE)/Txe(toxin)
experimentalExperimentally validated     insolicoBioinformatically predicted